Peripheral neuropathy in patients on long-term triazole antifungal therapy | Zendy

Caroline Baxter | Zendy; A. Marshall | Zendy; Mary M. Roberts | Zendy; Tim Felton | Zendy; David W. Denning | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Peripheral neuropathy in patients on long-term triazole antifungal therapy

Author(s) -

Caroline Baxter,

A. Marshall,

Mary M. Roberts,

Tim Felton,

David W. Denning

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr233

Subject(s) - medicine , aspergillosis , voriconazole , posaconazole , itraconazole , incidence (geometry) , surgery , retrospective cohort study , context (archaeology) , mycosis , dermatology , antifungal , immunology , paleontology , physics , optics , biology

Triazole antifungal drugs are the mainstay of treatment for patients with chronic pulmonary aspergillosis and are often used as steroid-sparing agents in patients with allergic aspergillosis. Peripheral neuropathy (PN) is a rare but reported side effect of triazole therapy in the acute management of invasive fungal infections, but its incidence during long-term triazole treatment for chronic aspergillosis is unknown. The goal of this study was to determine the incidence of PN in this context.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research